Immunai
Decoding immunity
Immunai was founded in 2018, is headquartered in New York, United States, lists 51–200 employees, and has $295.0M in recorded funding across 3 rounds.
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- immunai.com
- Total Funding
- $295.0M
- Last Round
- $215.0M Series BOct 2021
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.
About
Immunai is a multidisciplinary biotech company on a mission to fully map the immune system to revolutionize drug discovery and development. Central to its efforts is AMICA, a comprehensive single-cell immune data foundation built through organic development and two key acquisitions: Dropprint Genomics (March 2021), a Y Combinator-backed single-cell genomics software company, and Nebion (July 2021), a world leader in biocuration and data integration. Using single-cell multiomics and machine learning, Immunai builds high-resolution profiles of immune cells to predict patient responses to treatments and identify novel therapeutic targets for oncology and inflammatory diseases. The company works with leading academic centers and biopharmaceutical partners including AstraZeneca and Teva. Founded in December 2018 by CEO Noam Solomon, PhD, Immunai is headquartered in New York City with offices in Tel Aviv, Prague, and Zurich, and a team of 80+ PhDs across immunology, engineering, drug development, computer science, and entrepreneurship.
Summary
Immunai is an Artificial Intelligence company based in New York, United States, founded in 2018. It lists 51–200 employees. It has raised $295.0M in total across 3 rounds, most recently a $215.0M Series B round in Oct 2021. Investors include TLV Partners.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2021
Sign up to see all 3 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immunai"><img src="https://indexed.vc/api/badge/company/immunai" alt="Immunai on Indexed.vc" width="260" height="76" /></a>